At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
Zinc Oxide and Avobenzonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light
In Brief
A clinical study evaluating Zinc Oxide and Avobenzone for Sun Damaged Skin. Completed, enrolled 17 participants across 1 site.
Detailed Summary
The objective of this study is quantification of singlet oxygen species in the skin after exposure to Ultraviolet A (UVA) light
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSun Damaged Skin
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMar 2017
Primary CompletionFeb 2018
First PostedMay 2023
TodayJul 2026
First PostedMay 18, 2023
Enrollment StartMar 17, 2017
Primary CompletionFeb 2, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.1 years ago
Interventions
Zinc Oxide and Avobenzonedrug
Zinc Oxide is applied to one area of the forearm, Avobenzone is applied to another area of the forearm.